Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

CORRECTED-EU signs joint procurement contract for remdesivir supply

Thu, 08th Oct 2020 08:18

(Corrects after European Commission says 37 signatories not 36)

BRUSSELS, Oct 8 (Reuters) - The European Commission said on
Thursday it had signed a contract with U.S. drugmaker Gilead
for the supply of up to 500,000 treatment courses for
remdesivir, sharply increasing the supply of the COVID-19
treatment in Europe.

The Commission, which has overseen joint purchases of
vaccines in the European Union, said there were 37 signatories
to the agreement, including all EU countries, six Balkan
candidate and potential EU members, Britain and the other
European Economic Area countries Iceland, Liechtenstein and
Norway.

(Reporting by Marine Strauss and Philip Blenkinsop; Editing by
Edmund Blair)

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.